It is worth to noticing, that the effect of SIRT7 in controlling PD-L1-mediated immune responses strikingly diverges from HCC, where SIRT7 actually suppresses PD-L1 expression by inhibiting the MEF2D transcription factor [59]. Here, SIRT7 is linked to hepatocellular carcinoma.